Medical and pharmaceutical industry is an important part of China's national economy. It is predicted that thegross value of industrial outputof China's pharmaceutical industry will grow at a compound annual growth rate(CAGR)of 22% in the next ten years. The medical industry is of strategic importance, anditshealthy development is economically and socially crucial. This project focuses on sorting andstudyingthemedicine-related reform policies at the macro level, so as to combine qualitative and quantitative methods, and publish reports for policy-makers as well as academia. At the micro level,wemainly explore new business models and study future development trends for the pharmaceutical production industry, pharmaceutical distribution industry and other related industries.
